Bevacizumab for brain tumors has a certain effect, this product is commonly used in the treatment of various types of metastatic cancer, but the specific effect should be analyzed according to the type of disease. The effect of bevacizumab on the treatment of recurrent glioblastoma is relatively clear. It is observed through the test results that after the use of bevacizumab in patients with glial encephaloblastoma, it can significantly control the condition, reduce the level of tumor markers in the body, and help the patients to improve the quality of survival and delay the development of the disease, but the use of the medication should be in accordance with the doctor’s instructions. If it belongs to meningioma, germ cell tumor, chordoma, etc., bevacizumab can be used to reduce the symptoms and delay the progress of the patient’s condition. However, most patients can not achieve the therapeutic effect by using this product alone, so it should be combined with other anti-tumor drugs, such as erlotinib, temozolomide, etc., and the medication should be strictly in accordance with the doctor’s instructions. Brain tumor patients should be regularly observed during the use of bevacizumab, if the effect is not good, we should consult the doctor in time, and adjust the treatment plan under the guidance of the doctor.